| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |